Baxolele Mhlekude

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 6

Top Topics

Bone Regeneration

Angiotensin Converting Enzyme

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Markus Stempel, Oliver Maier, Baxolele Mhlekude, Alexander Drakesmith, Melanie M Brinkmann
Novel role of bone morphogenetic protein 9 in innate host responses to HCMV infection. EMBO reports 25 (3) (2024)
Markus Stempel, Oliver Maier, Baxolele Mhlekude, Alexander Drakesmith, Melanie M Brinkmann
Novel role of bone morphogenetic protein 9 in innate host responses to HCMV infection. EMBO reports 25 (3) (2024)
Markus Stempel, Oliver Maier, Baxolele Mhlekude, Alexander Drakesmith, Melanie M Brinkmann
Novel role of bone morphogenetic protein 9 in innate host responses to HCMV infection. EMBO reports 25 (3) (2024)
Markus Stempel, Oliver Maier, Baxolele Mhlekude, Alexander Drakesmith, Melanie M Brinkmann
Novel role of bone morphogenetic protein 9 in innate host responses to HCMV infection. EMBO reports (2024)
Markus Stempel, Oliver Maier, Baxolele Mhlekude, Alexander Drakesmith, Melanie M Brinkmann
Novel role of bone morphogenetic protein 9 in innate host responses to HCMV infection. EMBO reports (2024)
Baxolele Mhlekude, Dylan Postmus, Saskia Stenzel, January Weiner, Jenny Jansen, Francisco J Zapatero-Belinchón, Ruth Olmer, Anja Richter, Julian Heinze, Nicolas Heinemann, Barbara Mühlemann, Simon Schroeder, Terry C Jones, Marcel A Müller, Christian Drosten, Andreas Pich, Volker Thiel, Ulrich Martin, Daniela Niemeyer, Gisa Gerold, Dieter Beule, Christine Goffinet
Pharmacological inhibition of bromodomain and extra-terminal proteins induces an NRF-2-mediated antiviral state that is subverted by SARS-CoV-2 infection. PLoS pathogens 19 (9) (2023)